You are here: Lenkinski Lab»Publications


High-resolution computed tomography of single breast cancer microcalcifications in vivo.

Inoue K, Liu F, Hoppin J, Lunsford EP, Lackas C, Hesterman J, Lenkinski RE, Fujii H, Frangioni JV Mol Imaging 2011 Aug 10 4 295-304

Accurate prostate volume estimation using multifeature active shape models on T2-weighted MRI.

Toth R, Bloch BN, Genega EM, Rofsky NM, Lenkinski RE, Rosen MA, Kalyanpur A, Pungavkar S, Madabhushi A Acad Radiol 2011 Jun 18 6 745-54

Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging.

Tokuda J, Mamata H, Gill RR, Hata N, Kikinis R, Padera RF, Lenkinski RE, Sugarbaker DJ, Hatabu H J Magn Reson Imaging 2011 Apr 33 4 968-73

Perfusion imaging with a freely diffusible hyperpolarized contrast agent.

Grant AK, Vinogradov E, Wang X, Lenkinski RE, Alsop DC Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2011 Mar 746-55

Determining histology-MRI slice correspondences for defining MRI-based disease signatures of prostate cancer.

Xiao G, Bloch BN, Chappelow J, Genega EM, Rofsky NM, Lenkinski RE, Tomaszewski J, Feldman MD, Rosen M, Madabhushi A Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 2011 Jan 568-78

CEST and PARACEST MR contrast agents.

Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE Acta Radiol 2010 Oct 51 8 910-23

A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.

Liu F, Misra P, Lunsford EP, Vannah JT, Liu Y, Lenkinski RE, Frangioni JV Breast Cancer Res. Treat. 2010 Jul 122 1 87-94

Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.

Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H Invest Radiol 2010 Apr 45 4 174-81

A concentration-independent method to measure exchange rates in PARACEST agents.

Dixon WT, Ren J, Lubag AJ, Ratnakar J, Vinogradov E, Hancu I, Lenkinski RE, Sherry AD Magn Reson Med 2010 Mar 63 3 625-32

A multislice gradient echo pulse sequence for CEST imaging.

Dixon WT, Hancu I, Ratnakar SJ, Sherry AD, Lenkinski RE, Alsop DC Magn Reson Med 2010 Jan 63 1 253-6

Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast.

Lenkinski RE, Wang X, Elian M, Goldberg SN Magn Reson Med 2009 Jun 61 6 1286-92

Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?

Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN Radiology 2009 Jun 251 3 731-42

Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.

McMahon CJ, Bloch BN, Lenkinski RE, Rofsky NM Magn Reson Imaging Clin N Am 2009 May 17 2 363-83

An illustration of the potential for mapping MRI/MRS parameters with genetic over-expression profiles in human prostate cancer.

Lenkinski RE, Bloch BN, Liu F, Frangioni JV, Perner S, Rubin MA, Genega EM, Rofsky NM, Gaston SM MAGMA 2008 Nov 21 6 411-21

Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification.

Liu F, Bloch N, Bhushan KR, De Grand AM, Tanaka E, Solazzo S, Mertyna PM, Goldberg N, Frangioni JV, Lenkinski RE Mol Imaging 2008 Jul-Aug 7 4 175-86